Principal Securities Inc. Acquires 152 Shares of Integer Holdings Co. (NYSE:ITGR)

Principal Securities Inc. boosted its holdings in Integer Holdings Co. (NYSE:ITGR) by 31.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 639 shares of the medical equipment provider’s stock after purchasing an additional 152 shares during the period. Principal Securities Inc.’s holdings in Integer were worth $85,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Mather Group LLC. grew its position in shares of Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 143 shares during the period. Huntington National Bank grew its position in shares of Integer by 8,933.3% in the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 268 shares during the period. R Squared Ltd bought a new position in shares of Integer in the 4th quarter valued at about $44,000. Versant Capital Management Inc grew its position in shares of Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after acquiring an additional 183 shares during the period. Finally, Contravisory Investment Management Inc. grew its position in shares of Integer by 210.8% in the 4th quarter. Contravisory Investment Management Inc. now owns 693 shares of the medical equipment provider’s stock valued at $92,000 after acquiring an additional 470 shares during the period. Institutional investors own 99.29% of the company’s stock.

Integer Price Performance

Shares of Integer stock opened at $126.34 on Thursday. Integer Holdings Co. has a twelve month low of $103.08 and a twelve month high of $146.36. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The company has a 50-day simple moving average of $137.24 and a two-hundred day simple moving average of $132.84. The stock has a market capitalization of $4.25 billion, a price-to-earnings ratio of 37.60, a price-to-earnings-growth ratio of 1.72 and a beta of 1.13.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The business had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current year.

Wall Street Analyst Weigh In

ITGR has been the subject of a number of analyst reports. Truist Financial lifted their price objective on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Wells Fargo & Company reissued an “overweight” rating and issued a $160.00 price objective on shares of Integer in a research report on Tuesday, December 3rd. Oppenheimer downgraded shares of Integer from an “outperform” rating to a “market perform” rating in a research report on Friday, February 21st. Benchmark raised their target price on shares of Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Friday, February 21st. Finally, Citigroup raised their target price on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 11th. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $147.67.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.